Princess Margaret Cancer Centre — Toronto, Ontario

Public research footprint of Princess Margaret Cancer Centre, compiled from the ClinicalTrials.gov public registry.

884

Registered studies

449

Active

237

Recruiting now

306

Completed

109

Stopped or withdrawn

Most-studied conditions

Lymphoma, Large B-Cell, Diffuse · Neoplasms · Advanced Colorectal Cancer (Part 1) · Multiple Myeloma

Recently updated registry entries

NCT05488314 — A Study of Amivantamab and Capmatinib Combination Therapy in Unresectable Metastatic… (Active Not Recruiting)
NCT03767244 — A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced… (Active Not Recruiting)
NCT03394365 — A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Princess Margaret Cancer Centre?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.